CANNABIDIOL
DrugBank ID: db09061
DrugCentral: cannabidiol
Synonymous :(−)-trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol | (−)-trans-cannabidiol | (1’r,2’r)-5’-methyl-4-pentyl-2’-(prop-1-en-2-yl)-1’,2’,3’,4’-tetrahydrobiphenyl-2,6-diol | cannabidiol | cbd | δ1(2)-trans-cannabidiol
Drug Sentece Context
Table 1. Analysis of context sentence of cannabidiol gene in 2 abstracts.
| pmid | sentence |
|---|---|
| 32519753 | We suggest the hypothesis that Cannabidiol (CBD), a non-psychotropic phytocannabinoid, has the potential to limit the severity and progression of the disease for several reasons: 1) High-CBD Cannabis Sativa extracts are able to downregulate the expression of the two key receptors for SARS-CoV2 in several models of human epithelia 2) CBD exerts a wide range of immunomodulatory and anti-inflammatory effects and it can mitigate the uncontrolled cytokine production featuring Acute Lung Injury 3) Being a PPARγ agonist, it can display a direct antiviral activity 4) PPARγ agonists are regulators of fibroblast/myofibroblast activation and can inhibit the development of pulmonary fibrosis, thus ameliorating lung function in recovered patients. |
| 32699671 | Many cannabidiol (CBD) retailers make unsupported medical claims about their product. |
| 32804502 | This Perspective of the published essential medicinal chemistry of cannabidiol (CBD) provides evidence that the popularization of CBD-fortified or CBD-labeled health products and CBD-associated health claims lacks a rigorous scientific foundation. |
| 32923657 | Among all cannabinoids, cannabidiol (CBD) has demonstrated potent anti-inflammatory effects in a variety of pathological conditions. |
| 33001829 | There is some scientific evidence that vaping, cannabidiol (CBD - an active ingredient in cannabis from the hemp plant) or other substances, may be associated with more severe manifestations of COVID-19. |